跳至主要内容
临床试验/NCT06329284
NCT06329284已完成不适用

Midkine Interplays With Oxidative Stress and Inflammatory Milieu to Induce Preeclampsia in Normotensive Pregnant Women

Benha University2 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2023年1月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
80
试验地点
2
主要终点
Severity of Pre-Eclampsia (PE)

研究概览

简要总结

Preeclampsia (PE) is a hypertensive pregnancy-related disorder that endangers maternal and fetal outcomes and accounts for 9-10% of maternal mortalities with its early-onset phenotype is the most dangerous, but its etiology is still not fully elucidated.

Midkine (MDK) is a multifunctional protein that plays a unique role in the development of hypertension (HTN), via its proatherogenic effect and induction of overexpression of angiotensin converting enzyme. Oxidative stress (OS) upregulates the expression of MDK and MDK induces propagation of neoangiogenesis and acts as chemotactic for neutrophils.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
21 Years 至 50 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Newly pregnant normotensive (NT) women with singleton fetus;
  • Free of the Exclusion Criteria.

排除标准

  • Women with history of complicated pregnancy;
  • Had manifest essential hypertension, Diabetes Mellitus or chronic kidney diseases;
  • Had multiple gestational sacs, morbid obesity with Body Mass Index at time of pregnancy diagnosis over 35 kg/m2;
  • Had genetic disorders, coagulopathy, autoimmune diseases or maintained on immunosuppressive therapy.

研究组 & 干预措施

Serum Midkine

Other

干预措施: ELISA (Diagnostic Test)

结局指标

主要结局

Severity of Pre-Eclampsia (PE)

时间窗: 8 months

Correlation between Serum midkine levels and blood pressure measurements

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Shereen Naguib

Lecturer of Obstetrics & Gynecology, Faculty of Medicine

Benha University

研究点 (2)

Loading locations...

相似试验